Snss stock after hours

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly   SNSS | Complete Sunesis Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices After Hours Volume: 62. Health Care/Life Sciences   Sunesis Pharmaceuticals Inc. advanced stock charts by MarketWatch. View SNSS historial stock data and compare to other stocks and exchanges.

On The Fly: After Hours Movers. Urban Outfitters (URBN), up 2.3%. ALSO HIGHER: Celsion (CLSN), up 20.6% after the stock was initiated with an Outperform rating at Oppenheimer Sunesis (SNSS), up 4.9% after it was initiated with an Outperform rating at Oppenheimer Hain Celestial (HAIN), up 1.3% after Bloomberg reported that Nestle Sunesis Pharmaceuticals Inc., SNSS Quick Chart - (NAS ... Sunesis Pharma's stock, top Nasdaq decliner, plunges 68% after FDA update disappoints MarketWatch. 09:26 AM ET. Sunesis Pharmaceuticals downgraded to hold from buy at Cantor Fitzgerald MarketWatch. 09:26 AM ET. Sunesis Pharmaceuticals stock price target cut to $2 from $4 at Cantor Fitzgerald MarketWatch. 08:59 AM ET Sunesis Pharmaceuticals (NASDAQ:SNSS) Stock Price Up 9.1% ... Shares of Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) rose 9.1% during mid-day trading on Thursday . The company traded as high as $0.86 and last traded at $0.84, approximately 1,569,959 shares traded hands during mid-day trading. An increase of 10% from the average daily volume of 1,431,981 shares. The stock had previously closed at $0.77. Sunesis Announces Proposed Public Offering of Common Stock ... Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and Series F Convertible Preferred Stock in underwritten public offerings.

Sunesis Pharmaceuticals Inc., SNSS Quick Chart - (NAS ...

5 Feb 2020 Predictive Oncology Inc. - POAI Stock Chart Technical Analysis for to my own boss, and how you can too!: https://claytrader.com/1-hour-trader-. The Stock Trading Reality Podcast - https://claytrader.com/podcast/ Sunesis Pharmaceuticals, Inc. - SNSS Stock Chart Technical Restricted Mode: Off. 27 Aug 2014 (SNSS). For more free videos and content from ClayTrader check out the links below. Explore stocks with significant price movement or volume after regular trading ends. Sunesis Pharmaceuticals, Inc. (SNSS): Price and Financial Metrics SNSS Stock Price Chart More Charts. Created 200-day MA, $0.64, Market Cap, 49.63 M 

SNSS | Stock Snapshot - Fidelity

Sunesis Pharmaceuticals Inc. - NASDAQ:SNSS - Stock Quote ... Apr 02, 2020 · Explore commentary on Sunesis Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about SNSS. Sunesis readies stock offering; shares down … Sunesis Pharmaceuticals (NASDAQ:SNSS) Earnings | Benzinga Jan 01, 2010 · Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and SNSS - Sunesis Pharmaceuticals Inc Stock quote - CNNMoney.com Find real-time SNSS - Sunesis Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. SNSS - Sunesis Pharmaceuticals Inc Stock quote - CNNMoney.com Markets

Jul 10, 2019 · Sunesis Pharmaceuticals (SNSS) slumps 27% after hours in reaction to its public stock offering. Price, volume and terms have yet to be released.

Sunesis Pharma's stock, top Nasdaq decliner, plunges 68% after FDA update disappoints MarketWatch. 09:26 AM ET. Sunesis Pharmaceuticals downgraded to hold from buy at Cantor Fitzgerald MarketWatch. 09:26 AM ET. Sunesis Pharmaceuticals stock price target cut to $2 from $4 at Cantor Fitzgerald MarketWatch. 08:59 AM ET After-Hours Movers 07/10: (DVAX) (AIR) (BBBY) (SNSS) (PSMT ...

Sunesis... (SNSS) Stock Price VWAP | Premarket | After Hours

17 Mar 2020 Sunesis Pharmaceuticals, Inc. (SNSS) - free report >> Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the For 32 years, our Strong Buy list has averaged returns more than twice the market. View the real-time SNSS price chart on Robinhood and decide if you want to buy or sell commission-free. read news, get earnings results, and compare Sunesis against related stocks Down$0.01 (1.85%)As of 5:00 PM PDT after-hours. View live SUNESIS PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, SNSS financials and market news. 9 Mar 2020 Inc. [SNSS] is a Good Choice for Investors After New Price Target of $3.50 Sunesis Pharmaceuticals Inc. [NASDAQ: SNSS] stock went on an upward is currently 2.20, trading closer to a bullish pattern in the stock market. 10 Jul 2019 SNSS) 22.5% LOWER; today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock  25 Feb 2020 Sunesis Pharmaceuticals Inc. (SNSS) shares are taking a pay cut of After an ongoing check, Maxar Technologies Inc. (MAXR) stock is found  rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on SNSS. Stocks by Morningstar Classification 

Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of Sunesis, will present at the 28th Annual Credit Suisse Healthcare Conference on Wednesday, November 13, 2019 at 11:30 AM Mountain Time in Scottsdale, Arizona. Sunesis Pharmaceuticals, Inc. (SNSS) Market Stream ... Mar 30, 2020 · Stock Details Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain CHARTS Basic Chart Interactive Chart COMPANY NEWS Company Headlines Press Releases Market Stream STOCK ANALYSIS Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison FUNDAMENTALS What Sunesis Pharmaceuticals, Inc. (SNSS) Doesn’t Want You ... SNSS Stocks 101.42% Far from 50 Day Moving Average. After a stumble in the market that brought SNSS to its low price for the period of the last 52 weeks, Sunesis Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -41.81% of loss for the given period.